A Study for Prevention of Kidney Disease in Diabetic Patients (BENEDICT)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The BENEDICT study is conducted to examine the effects of an ACE inhibitor, calcium channel
blockade, a combination of these, and placebo, in the prevention of micro- and
macro-albuminuria in Type 2 diabetic patients.